Cargando…

The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

SIMPLE SUMMARY: This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Euhus, Caleb J., Ripley, Taylor R., Medina, Cristian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139825/
https://www.ncbi.nlm.nih.gov/pubmed/35626125
http://dx.doi.org/10.3390/cancers14102524
_version_ 1784714950383501312
author Euhus, Caleb J.
Ripley, Taylor R.
Medina, Cristian G.
author_facet Euhus, Caleb J.
Ripley, Taylor R.
Medina, Cristian G.
author_sort Euhus, Caleb J.
collection PubMed
description SIMPLE SUMMARY: This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. ABSTRACT: Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
format Online
Article
Text
id pubmed-9139825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91398252022-05-28 The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer Euhus, Caleb J. Ripley, Taylor R. Medina, Cristian G. Cancers (Basel) Article SIMPLE SUMMARY: This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. ABSTRACT: Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management. MDPI 2022-05-20 /pmc/articles/PMC9139825/ /pubmed/35626125 http://dx.doi.org/10.3390/cancers14102524 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Euhus, Caleb J.
Ripley, Taylor R.
Medina, Cristian G.
The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title_full The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title_fullStr The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title_full_unstemmed The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title_short The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
title_sort role of surgery for oligometastatic non-small cell lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139825/
https://www.ncbi.nlm.nih.gov/pubmed/35626125
http://dx.doi.org/10.3390/cancers14102524
work_keys_str_mv AT euhuscalebj theroleofsurgeryforoligometastaticnonsmallcelllungcancer
AT ripleytaylorr theroleofsurgeryforoligometastaticnonsmallcelllungcancer
AT medinacristiang theroleofsurgeryforoligometastaticnonsmallcelllungcancer
AT euhuscalebj roleofsurgeryforoligometastaticnonsmallcelllungcancer
AT ripleytaylorr roleofsurgeryforoligometastaticnonsmallcelllungcancer
AT medinacristiang roleofsurgeryforoligometastaticnonsmallcelllungcancer